Organogenesis Holdings Forecast, price target & analysts
Organogenesis Holdings Target price 2025 - Analyst rating & recommendation
Organogenesis Holdings Classifications & Recommendation:
Organogenesis Holdings Price Target
| Target Price | $8.16 |
| Price | $5.59 |
| Potential |
45.98%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Organogenesis Holdings 2026 .
The average Organogenesis Holdings target price is $8.16.
This is
45.98%
register free of charge
$9.45
69.05%
register free of charge
$7.07
26.48%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Organogenesis Holdings to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Organogenesis Holdings stock has an average upside potential 2026 of
45.98%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 482.04 | 494.14 |
| 11.29% | 2.51% | |
| EBITDA Margin | 8.00% | 8.07% |
| 24.17% | 0.94% | |
| Net Margin | -0.20% | -1.57% |
| 117.06% | 705.11% |
4 Analysts have issued a sales forecast Organogenesis Holdings 2025 . The average Organogenesis Holdings sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Organogenesis Holdings EBITDA forecast 2025. The average Organogenesis Holdings EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Organogenesis Holdings Analysts have issued a net profit forecast 2025. The average Organogenesis Holdings net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.01 | -0.06 |
| 125.00% | 500.00% | |
| P/E | negative | |
| EV/Sales | 1.31 |
4 Analysts have issued a Organogenesis Holdings forecast for earnings per share. The average Organogenesis Holdings EPS is
This results in the following potential growth metrics and future valuations:
Organogenesis Holdings...
Current Organogenesis Holdings Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 26 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 26 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jul 15 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 05 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
